PD-L1 and IDO1 are Expressed in Poorly-Differentiated Thyroid Carcinoma

BACKGROUND: Poorly differentiated thyroid carcinoma (PDTC) is an aggressive form of thyroid cancer that currently has limited effective treatment options. Immune checkpoint inhibitors (ICIs) have shown to be an effective treatment for a variety of carcinomas. In this study, we explore whether immune...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Endocr Pathol
Päätekijät: Rosenbaum, Matthew W., Gigliotti, Benjamin J., Pai, Sara I., Parangi, Sareh, Wachtel, Heather, Mino-Kenudson, Mari, Gunda, Viswanath, Faquin, William C.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500591/
https://ncbi.nlm.nih.gov/pubmed/29372535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12022-018-9514-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia